EndoTODAY | EndoATLAS | OPD

Parasite | Eso | Sto | Cancer | ESD

Boxim | DEX | Sono | Schedule

Home | Recent | Blog | Links


[SMC Monday GI conference 2017-8-14. Serrated polyposis syndrome]

Previous | Next

Serrated adenoma¶õ ´Ù¼Ò º¹ÀâÇÑ °³³äÀÔ´Ï´Ù.

EndoTODAY¿¡¼­´Â 2015³â 11¿ù 1ÀÏ °¡Å縯´ëÇб³ À̺¸ÀÎ ±³¼ö´ÔÀÇ ¼³¸íÀ» ¼Ò°³ÇÑ ¹Ù ÀÖ½À´Ï´Ù. ¾Æ·¡¿¡ ¿Å±é´Ï´Ù.

Serrated pathway´Â Å©°Ô sessile serrated pathway¿Í traditional serrated pathway·Î ³ª´©¾îÁý´Ï´Ù.

(1) ¿ì¸®°¡ interval cancerÀÇ ÁÖ¹üÀ¸·Î ¾Ë°í ÀÖ´Â serrated adenoma´Â ÁÖ·Î SSA (sessile serrated adenoma)¸¦ ¸»ÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ´Â ÁÖ·Î ¿ìÃø´ëÀå¿¡ ¹ß»ýÇϸç ÀϹÝÀûÀÎ hyperplastic polypº¸´Ù Å« °æÇâÀ» º¸ÀÔ´Ï´Ù. ÁÖº¯Á¡¸·¿¡ ºñÇØ À¶±â°¡ ¹Ì¹ÌÇϸç ÆòźÇÏ°í ¹ÝÅõ¸íÇϰųª paleÇÑ Á¡¸·À» ¶ç°í °æ°èµµ ºÒºÐ¸íÇÏ¿©¼­ ÁÖÀÇÇÏÁö ¾ÊÀ¸¸é ¹ß°ßÀÚü°¡ ¾î·Æ½À´Ï´Ù. À°¾ÈÀû Áø´ÜÀÇ clue´Â Á¡¾×À» ¸¹ÀÌ ºÐºñÇؼ­ Ç¥¸é¿¡ Àß ¾Ä±âÁö ¾Ê´Â mucous capÀ» °®°í ÀÖ´Ù´Â °ÍÀε¥ À̵µ 2/3¸¸ ÀÖ´Ù°í ÇÕ´Ï´Ù. È®´ë³»½Ã°æÀ» Çصµ ÁÖ·Î Kudo pit pattern type II¸¦ º¸¿©¼­ hyperplastic polyp°ú ±¸ºÐµµ ½±Áö ¾Ê½À´Ï´Ù. type II pitÀÌ mucous material·Î È®ÀåµÈ type II-O patternÀÌ ¹ß°ßµÇ´Âµ¥ ±¹¼ÒÀûÀ¸·Î¸¸ ³ªÅ¸³ª¸ç ¹Î°¨µµ°¡ ³·½À´Ï´Ù. NBI¿¡¼­µµ subepithelial capillary networkÀÌ ¾ÆÁÖ µå¹® NICE I pattern (Sano I, Showa - faint)À» º¸À̹ǷΠÀ°¾ÈÀû °¨º°ÀÌ ½±Áö ¾Ê½À´Ï´Ù. ÀÌ·Î ÀÎÇؼ­ Western¿¡¼­ ÁÖÀåÇÏ´ø resect and discard strategyÀÇ ¼öÁ¤ÀÌ Á¦¾ÈµÉ Á¤µµÀÔ´Ï´Ù. SSA¸¦ Àß ¸ð¸£´Â community pathologistµµ ¸¹±â ¶§¹®¿¡ ¿ìÃø´ëÀå¿¡ ¹ß°ßµÈ ³ÐÀº º´º¯Àº ÀýÁ¦Á¶Á÷¼Ò°ßÀÌ hyperplastic polypÀ¸·Î ³ª¿Íµµ SSA¿¡ ÁØÇØ FUÇÏÀÚ´Â ÁÖÀåµµ ÀÖ½À´Ï´Ù.

(2) TSA (traditional serrated adenoma)´Â ÁÖ·Î distal colorectum¿¡ À§Ä¡Çϸç SSAº¸´Ù µå¹°°Ô ¹ß°ßµË´Ï´Ù. Serrated polyp (hyperplastic polyp±îÁö Æ÷ÇÔ)ÀÇ 1% Á¤µµ¸¦ Â÷ÁöÇÕ´Ï´Ù. flatÇÑ Çüź¸´Ù protruded (sessile or pedunculated) ÇüŸ¦ °¡Áö¸ç Ç¥¸éµµ villous stricture¸¦ °¡Áö°í ¹ßÀûÀÌ ÀÖ´Â °æ¿ìµµ ¸¹¾Æ ¹ß°ßÀÌ ¾î·ÆÁö´Â ¾Ê½À´Ï´Ù. ¾ÏÈ­°¡´É¼ºµµ »ó´ëÀûÀ¸·Î ³ô¾Æ ÀϹÝÀûÀ¸·Î advanced adenoma¿¡ ÁØÇØ ÃßÀûÇÕ´Ï´Ù.

À̹ø ¿ù¿ä Áý´ãȸ¸¦ ÅëÇؼ­ °ü·Ã Àú³Î 2°³°¡ °ËÅäµÇ¾ú½À´Ï´Ù. ¸¶Áö¸·¿¡ ±èÅÂÁØ ±³¼ö´Ô²²¼­ Àß Á¤¸®ÇØ Áּ̽À´Ï´Ù. °¨»çÇÕ´Ï´Ù.


1. Low prevalence of serrated polyposis syndrome in screening populations: a systematic review Endoscopy 2015

PPT PDF 0.7M (Àü°øÀÇ ±èÁöÀ¯)

CONCLUSION: The true prevalence of SPS is unclear because of the risk of bias across studies, but is likely to be below 0.09% as derived from primary colonoscopy screening programs. The prevalence in pre-selected screening populations after positive fecal testing is higher, with reported values of 0.34% and 0.66%.


2. Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study Gut 2016

PPT PDF 1.1M (fellow À̼ÒÁ¤)

CONCLUSION: Patients with SPS have an increased risk of CRC, although lower than previously published. Close colonoscopy surveillance in experienced centres show a low risk of developing CRC (1.9% in 5years). Specific polyp features (SSA/P histology, proximal location and presence of high-grade dysplasia) should be used to guide clinical management.


3. ±èÅÂÁØ ±³¼ö´ÔÀÇ Çؼ³

Serrated polyposis syndromeÀº (1) multiple serrated polypÀÇ ¹ß»ý°ú ÀÌ·Î ÀÎÇÑ (2) ³ôÀº ´ëÀå¾Ï ¹ß»ýÀÇ ÀÓ»óÀû Ư¡À» °¡Áö¸ç (3) serrated pathwayÀÇ genetic background¸¦ °¡Áö´Â µå¹® ÁúȯÀÔ´Ï´Ù.

SPSÀÇ prevalence¸¦ º¸°íÇÑ 6°³ÀÇ ¿¬±¸¸¦ Á¾ÇÕÇغ¸¸é primary colonoscopy screening population¿¡¼­´Â prevalence°¡ 0.09% ÀÌÇÏ¿´°í fecal occult blood positive ±×·ì¿¡¼­´Â 0.34 - 0.66% Á¤µµ º¸°íµÇ¾ú½À´Ï´Ù. 1000°³ÀÇ primary screening colonoscopy¸¦ ÇÏ¸é ¾à 1¸í Á¤µµ ¸¸³­´Ù´Â ¾ê±âÀ̸ç FOBT positive screening population¿¡¼­´Â ¾à 5¸í Á¤µµ ¹ß°ßÇÒ ¼ö ÀÖ´Ù´Â °Ì´Ï´Ù. ÀÌ·¸°Ô ³·Àº prevalenceÀÌÁö¸¸ ÀÌ »ç¶÷µéÀÌ colorectal cancer ±×¸®°í interval colorectal cancerÀÇ high risk À̱⠶§¹®¿¡ ´ëÀå³»½Ã°æÀ» ÇÏ´Â ÀÇ»ç¶ó¸é ²À ¾Ë¾Æ¾ß ÇÕ´Ï´Ù.

ÇöÀç US Multi-Society Task Force¿Í European guideline¿¡¼­´Â 1-year surveillance intervalÀ» Ç϶ó°í ±Ç°íÇÏ°í ÀÖ½À´Ï´Ù. ´ëÀå³»½Ã°æ½Ã Á¾Á¾ ¸¸³ª´Â high risk group (3°³ÀÇ ÀÌ»óÀÇ ¼±Á¾À̰ųª °íµµ¼±Á¾)ÀÇ surveillance intervalÀÌ 3³âÀÎ °É »ý°¢Çغ¸¸é ¸Å¿ì ªÀº intervalÀÔ´Ï´Ù.

±×·¯³ª ÃÖ±Ù ¹ßÇ¥µÈ ³í¹®¿¡¼­´Â ÀÌÀü º¸°íµéº¸´Ù ´ëÀå¾Ï À§Çèµµ°¡ ±×·¸°Ô ³ôÁö´Â ¾Ê¾Ò°í annual surveillance colonoscopy ¸¦ ½ÃÇà ¹ÞÀº ȯÀÚµéÀº 5-year cumulative incidence°¡ 1.9%·Î ³ôÁö ¾Ê¾Ò½À´Ï´Ù. ¶ÇÇÑ SPS ȯÀÚ±º Áß¿¡¼­µµ SSA/P histology, proximal location, high grade dysplasia ¸¦ °¡Áø »ç¶÷ÀÌ »ó´ëÀûÀ¸·Î ´õ ³ôÀº ´ëÀå¾Ï À§Çèµµ¸¦ º¸¿© distal colon¿¡ 20°³ ÀÌ»óÀÇ ÀÛÀº serrated polypÀ» °¡Áø »ç¶÷°ú´Â Â÷ÀÌ°¡ ÀÖ¾ú½À´Ï´Ù. ´õ ¸¹Àº ¿¬±¸°¡ ÇÊ¿äÇÏÁö¸¸ low risk ȯÀÚµéÀº annual surveillance interval¸¦ Á» ´õ ´Ã·Áº¼ ¼ö ÀÖÀ» °Í °°½À´Ï´Ù. (ex; 1³â-> 3³â)


[References]

* Âü°í: EndoTODAY Serrated adenoma of the colon

* Âü°í: EndoTODAY Serrated adenoma (or serrated adenocarcinoma) of the stomach


[References]

1) SMC Endoscopy Unit »ï¼º¼­¿ïº´¿ø ³»½Ã°æ½Ç

2) SMC Monday GI conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¿ù¿äÁ¡½É¼ÒÈ­±âÁý´ãȸ

3) SMC Thursday endoscopy conference »ï¼º¼­¿ïº´¿ø ÀÏ¿ø³»½Ã°æ±³½Ç ¸ñ¿äÁ¡½É³»½Ã°æÁý´ãȸ

© ÀÏ¿ø³»½Ã°æ±³½Ç ¹Ù¸¥³»½Ã°æ¿¬±¸¼Ò ÀÌÁØÇà. EndoTODAY Endoscopy Learning Center. Lee Jun Haeng.